Is Celularity Stock a Good Investment?
Celularity Investment Advice | CELUW |
- Examine Celularity's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Celularity's leadership team and their track record. Good management can help Celularity navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Celularity's business and its evolving consumer preferences.
- Compare Celularity's performance and market position to its competitors. Analyze how Celularity is positioned in terms of product offerings, innovation, and market share.
- Check if Celularity pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Celularity's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Celularity stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Celularity is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Celularity Stock
Researching Celularity's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.87. Celularity had not issued any dividends in recent years.
To determine if Celularity is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Celularity's research are outlined below:
| Celularity is way too risky over 90 days horizon | |
| Celularity has some characteristics of a very speculative penny stock | |
| Celularity appears to be risky and price may revert if volatility continues | |
| Celularity has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 39.23 M. | |
| Celularity has accumulated about 38 M in cash with (6.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Celularity's profitablity analysis
The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.52.Determining Celularity's profitability involves analyzing its financial statements and using various financial metrics to determine if Celularity is a good buy. For example, gross profit margin measures Celularity's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Celularity's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Celularity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Celularity. Check Celularity's Beneish M Score to see the likelihood of Celularity's management manipulating its earnings.
Basic technical analysis of Celularity Stock
As of the 23rd of July, Celularity shows the Risk Adjusted Performance of 0.1215, mean deviation of 16.75, and Downside Deviation of 19.39. Celularity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Celularity downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Celularity is priced correctly, providing market reflects its regular price of 0.0499 per share. As Celularity appears to be a penny stock we also recommend to validate its total risk alpha numbers.Celularity's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Celularity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Celularity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Celularity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Celularity's Outstanding Corporate Bonds
Celularity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Celularity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Celularity bonds can be classified according to their maturity, which is the date when Celularity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| CELARA 3875 02 NOV 27 Corp BondUS151191BB89 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| US15118JAA34 Corp BondUS15118JAA34 | View |
Understand Celularity's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Celularity's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1215 | |||
| Market Risk Adjusted Performance | 1.2 | |||
| Mean Deviation | 16.75 | |||
| Semi Deviation | 14.64 | |||
| Downside Deviation | 19.39 | |||
| Coefficient Of Variation | 795.94 | |||
| Standard Deviation | 26.87 | |||
| Variance | 722.13 | |||
| Information Ratio | 0.1176 | |||
| Jensen Alpha | 2.78 | |||
| Total Risk Alpha | (2.85) | |||
| Sortino Ratio | 0.163 | |||
| Treynor Ratio | 1.19 | |||
| Maximum Drawdown | 166.88 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 | |||
| Downside Variance | 376.15 | |||
| Semi Variance | 214.31 | |||
| Expected Short fall | (29.26) | |||
| Skewness | 2.04 | |||
| Kurtosis | 6.81 |
| Risk Adjusted Performance | 0.1215 | |||
| Market Risk Adjusted Performance | 1.2 | |||
| Mean Deviation | 16.75 | |||
| Semi Deviation | 14.64 | |||
| Downside Deviation | 19.39 | |||
| Coefficient Of Variation | 795.94 | |||
| Standard Deviation | 26.87 | |||
| Variance | 722.13 | |||
| Information Ratio | 0.1176 | |||
| Jensen Alpha | 2.78 | |||
| Total Risk Alpha | (2.85) | |||
| Sortino Ratio | 0.163 | |||
| Treynor Ratio | 1.19 | |||
| Maximum Drawdown | 166.88 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 | |||
| Downside Variance | 376.15 | |||
| Semi Variance | 214.31 | |||
| Expected Short fall | (29.26) | |||
| Skewness | 2.04 | |||
| Kurtosis | 6.81 |
Consider Celularity's intraday indicators
Celularity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Celularity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Celularity time-series forecasting models is one of many Celularity's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celularity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Celularity Stock media impact
There is far too much social signal, news, headlines, and media speculation about Celularity that are available to investors today. This information is accessible both publicly - through Celularity's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Celularity-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Celularity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Celularity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Celularity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Celularity alpha.
Celularity Corporate Management
| Carlos Ramirez | SVP Relations | Profile | |
| Sharmila MD | Senior Safety | Profile | |
| CFA CFA | Chief Officer | Profile | |
| Tim Wilk | Senior Operations | Profile | |
| Ramji Krishnan | Chief Officer | Profile | |
| Bradley Glover | Ex COO | Profile | |
| CPA MS | Treasurer | Profile |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.